Children's cancers, Neuroblastoma
Results
Phase 3
This trial was looking at chemotherapy and surgery for children over 1 year old who had neuroblastoma.
We use the term ‘you’ in this summary, but of course if you are a parent, we are referring to your child.
Neuroblastoma is a rare type of cancer that develops in nerve cells, most commonly in nerve cells of the . It usually affects babies and young children.
Children with neuroblastoma usually have a combination of treatments including surgery, chemotherapy and radiotherapy.
This trial was for children who had localised cancer that could not be removed with surgery. Localised means that there are no signs that the cancer has spread to other parts of the body.
Some children with neuroblastoma have too many copies of a gene called . This is known as MYCN amplification and can affect how neuroblastoma responds to treatment. The children taking part in this trial did not have MYCN amplification
The trial treatment plan was chemotherapy followed by surgery. The aim was to find out how well this treatment worked for children over 1 year old with localised neuroblastoma.
Recruitment start: 11 May 2001
Recruitment end: 23 February 2006
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr J. Kohler
Cancer Research UK Children's Cancer Trials Team
University of Birmingham
Children's Cancer and Leukaemia Group (CCLG)
National Institute for Health Research Cancer Research Network (NCRN)
University Hospitals of Leicester NHS Trust
University of Birmingham
Last reviewed: 26 Jun 2014
CRUK internal database number: 240